The stark reality that heart disease kills more pregnant women than any other cause in America reveals a preventable crisis that disproportionately claims Black mothers' lives. This pattern exposes systemic gaps in reproductive healthcare that evidence-based interventions could dramatically narrow.
Cardiovascular complications now represent the primary threat to maternal survival, with cardiomyopathy, heart attacks, and hypertensive crises driving fatalities during pregnancy and postpartum periods. Pre-existing conditions including hypertension, diabetes, obesity, and dyslipidemia amplify these risks substantially. The modified WHO 2.0 classification system provides validated risk stratification for women with known heart conditions, while biomarkers like N-terminal pro-B-type natriuretic peptide help distinguish normal pregnancy breathlessness from dangerous heart failure symptoms.
This comprehensive clinical review illuminates a crucial prevention opportunity that extends far beyond obstetric care. The evidence strongly supports prepregnancy cardiovascular optimization through aggressive management of modifiable risk factors, suggesting that internists and cardiologists play essential roles in maternal mortality prevention. Standardized perinatal assessment algorithms and remote postpartum monitoring protocols show promise for reducing diagnostic delays and care disparities. However, the persistent racial inequities in maternal cardiovascular deaths reflect deeper healthcare access and quality issues that technical solutions alone cannot resolve. While these clinical advances offer hope for reducing preventable deaths, achieving meaningful progress requires addressing the structural barriers that prevent optimal prepregnancy care for vulnerable populations. The stakes are clear: systematic implementation of these evidence-based approaches could save hundreds of maternal lives annually.